PIAS1 is a determinant of poor survival and acts as a positive feedback regulator of AR signaling through enhanced AR stabilization in prostate cancer

por Puhr, M, Hoefer, J, Eigentler, A, Dietrich, D, van Leenders, G, Uhl, B, Hoogland, M, Handle, F, Schlick, B, Neuwirt, H, Sailer, V, Kristiansen, G, Klocker, H, Culig, Z
Publicado 2016

Real world analysis of high-cut-off (HCO) hemodialysis with bortezomib-based backbone therapy in patients with multiple myeloma and acute kidney injury

por Steiner, N., Abdel Hamid, A., Kronbichler, A., Neuwirt, H., Myslivecek, M., Kollar, M., Lachmanova, J., Rysava, R., Hruskova, Z., Spicka, I., Willenbacher, W., Nachbaur, D., Wolf, D., Tesar, V., Gunsilius, E.
Publicado 2020